Katsuhiro Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katsuhiro Suzuki has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Seiji Hayashi
Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Centre, Sakai City, Osaka, Japan
5 shared publications - Shiomi Yoshida
Clinical Research Center, Nho Kinki Chuo Chest Medical Center
4 shared publications - Yu Kurahara
Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Japan
4 shared publications - Kazunari Tsuyuguchi
Department of Infectious Diseases, National Hospital Organization, Kinki-Chuo Chest Medical Center, Japan
3 shared publications Hajime Saito
2 shared publications- Kazunobu Tachibana
Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Nagasone-cho 1180, Kita-ku, Sakai-city 591-8555, Osaka, Japan
2 shared publications
Latest Publications
- 1 July 2018
- Published by Elsevier in Respiratory Investigation
- Vol. 56 (4) , 326-331
Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease
- 1 July 2018
- Published by Elsevier in Respiratory Investigation
- Vol. 56 (4) , 326-331
Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease
- Open Access
- 1 January 2018
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 57 (1) , 13-16
Clinical Features of Nontuberculous Mycobacterial Pleurisy: A Review of 12 Cases
Objective The incidence of pulmonary nontuberculous mycobacterial (NTM) infections has increased in recent decades. Nevertheless, NTM pleurisy is still a rare disease. The objective of the present study was to elucidate the clinical features and outcomes of NTM pleurisy. Methods A retrospective study was undertaken of consecutive patients whose pleural effusion culture yielded NTM, from 2002 to 2016 at a respiratory hospital in Japan. The clinical features, treatment, and outcomes of these patients were analyzed. Result The 12 patients with NTM pleurisy were predominantly male, with a median age of 69 years (range, 48-93 years). They included eight patients with a history of smoking and six patients with immunosuppressive comorbidities such as malignancy, diabetes mellitus, and conditions requiring steroid administration. Fibrocavitary disease was the most common radiographic feature of these patients, and Mycobacterium avium complex was the most common pathogen. Pneumothorax was complicated in 11 patients. Surgery was performed on seven patients, in addition to thoracic drainage for the treatment of pleurisy and pneumothorax. Three patients died of respiratory failure. Conclusion Pneumothorax is a frequent complication of NTM pleurisy, often making the condition difficult to treat. Surgery at an appropriate time should therefore considered for refractory cases.
- 1 January 2018
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 57 (1) , 13-16
Open AccessClinical Features of Nontuberculous Mycobacterial Pleurisy: A Review of 12 Cases
Objective The incidence of pulmonary nontuberculous mycobacterial (NTM) infections has increased in recent decades. Nevertheless, NTM pleurisy is still a rare disease. The objective of the present study was to elucidate the clinical features and outcomes of NTM pleurisy. Methods A retrospective study was undertaken of consecutive patients whose pleural effusion culture yielded NTM, from 2002 to 2016 at a respiratory hospital in Japan. The clinical features, treatment, and outcomes of these patients were analyzed. Result The 12 patients with NTM pleurisy were predominantly male, with a median age of 69 years (range, 48-93 years). They included eight patients with a history of smoking and six patients with immunosuppressive comorbidities such as malignancy, diabetes mellitus, and conditions requiring steroid administration. Fibrocavitary disease was the most common radiographic feature of these patients, and Mycobacterium avium complex was the most common pathogen. Pneumothorax was complicated in 11 patients. Surgery was performed on seven patients, in addition to thoracic drainage for the treatment of pleurisy and pneumothorax. Three patients died of respiratory failure. Conclusion Pneumothorax is a frequent complication of NTM pleurisy, often making the condition difficult to treat. Surgery at an appropriate time should therefore considered for refractory cases.
- 1 January 2018
- Published by Elsevier in Respiratory Investigation
- Vol. 56 (1) , 87-93
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance
- 1 January 2018
- Published by Elsevier in Respiratory Investigation
- Vol. 56 (1) , 87-93
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance
- 1 January 2017
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 21 (1) , 124-126
A case of Mycobacterium abscessus subsp. massiliense lung disease complicated by lipoid pneumonia
- 1 January 2017
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 21 (1) , 124-126
A case of Mycobacterium abscessus subsp. massiliense lung disease complicated by lipoid pneumonia
- 1 January 2017
- Published by Elsevier in Respiratory Investigation
- Vol. 55 (1) , 45-50
Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases
- 1 January 2017
- Published by Elsevier in Respiratory Investigation
- Vol. 55 (1) , 45-50
Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases
- Open Access
- 1 May 2014
- Published by Elsevier in Respiratory Investigation
- Vol. 52 (3) , 160-166
Pulmonary nocardiosis: A clinical analysis of 59 cases
- 1 May 2014
- Published by Elsevier in Respiratory Investigation
- Vol. 52 (3) , 160-166
Open AccessPulmonary nocardiosis: A clinical analysis of 59 cases
- 1 July 2011
- Vol. 86 (7) , 681-4
[Present status of studies on epidemiology and molecular epidemiology of Mycobacterium kansasii, in special reference to its molecular epidemiology].
There appears to be some genetic diversity among Mycobacterium kansasii (M. kansasii) isolates recovered throughout the world. Restriction analysis of heat shock protein 65-polymerase chain reaction-restriction analysis (hsp65PRA) showed that M. kansasii contains seven subspecies genetically distinct from M. kansasii isolates. M. kansasii genotype I is predominant in Japan and shows a very tight clonal structure. Different molecular typing methods including the 16S-23S rRNA spacer (ITS) region, RFLP, and PFGE analysis have been applied to isolates worldwide, and M. kansasii genotype I, as defined by hsp65PRA, appears to be highly clonal and the most common genotype associated with human disease. However, the identification of M. kansasii at the subtype level may possibly be more than just an interesting epidemiological tool; it may be relevant to determining the infectious pathway and clinical management of individual cases, as it allows the differentiation of potentially pathogenic subtypes from nonpathogenic subtypes. This review has been followed by the first review of the epidemiology of M. kansasii, and summarizes the evidence of molecular epidemiology and establishes the validity and importance of studies of M. kansasii. Further, the more precise definition of various M. kansasii isolates herein should provide a significant contribution to the understanding of key aspects of its biology, genotype, and molecular epidemiology.
- 1 July 2011
- Vol. 86 (7) , 681-4
[Present status of studies on epidemiology and molecular epidemiology of Mycobacterium kansasii, in special reference to its molecular epidemiology].
There appears to be some genetic diversity among Mycobacterium kansasii (M. kansasii) isolates recovered throughout the world. Restriction analysis of heat shock protein 65-polymerase chain reaction-restriction analysis (hsp65PRA) showed that M. kansasii contains seven subspecies genetically distinct from M. kansasii isolates. M. kansasii genotype I is predominant in Japan and shows a very tight clonal structure. Different molecular typing methods including the 16S-23S rRNA spacer (ITS) region, RFLP, and PFGE analysis have been applied to isolates worldwide, and M. kansasii genotype I, as defined by hsp65PRA, appears to be highly clonal and the most common genotype associated with human disease. However, the identification of M. kansasii at the subtype level may possibly be more than just an interesting epidemiological tool; it may be relevant to determining the infectious pathway and clinical management of individual cases, as it allows the differentiation of potentially pathogenic subtypes from nonpathogenic subtypes. This review has been followed by the first review of the epidemiology of M. kansasii, and summarizes the evidence of molecular epidemiology and establishes the validity and importance of studies of M. kansasii. Further, the more precise definition of various M. kansasii isolates herein should provide a significant contribution to the understanding of key aspects of its biology, genotype, and molecular epidemiology.
- 1 May 2011
- Vol. 86 (5) , 515-21
[Present status of studies on epidemiology and molecular epidemiology of Mycobacterium kansasii, in special reference to its epidemiology].
Mycobacterium kansasii, a slow-growing photochromogen, causes serious pulmonary diseases in humans. Since the 1980s the isolation rate of M. kansasii has been surpassed by that of Mycobacterium avium complex (MAC). Pulmonary disease caused by M. kansasii is known to be more common in urban areas than in rural areas, and its changing epidemiologic features and geographical distribution have been known for several decades. The disease had been found almost only in and around Tokyo areas until the 1970s, but after the 1990s, the disease spread to the rest of Japan. The incidence rate of the disease due to M. kansasii remained at the same level, while non-tuberculous mycobacterioses as a whole are rapidly increasing, especially because of the increase in Mycobacteriu avium complex diseases, and because of the improvement of identification techniques in recent years. This change in the epidemiologic picture of M. kansasii in Japan seems to be influenced by the international trends of this disease. The complicated environmental and other factors related to M. kansasii infection are discussed in this review.
- 1 May 2011
- Vol. 86 (5) , 515-21
[Present status of studies on epidemiology and molecular epidemiology of Mycobacterium kansasii, in special reference to its epidemiology].
Mycobacterium kansasii, a slow-growing photochromogen, causes serious pulmonary diseases in humans. Since the 1980s the isolation rate of M. kansasii has been surpassed by that of Mycobacterium avium complex (MAC). Pulmonary disease caused by M. kansasii is known to be more common in urban areas than in rural areas, and its changing epidemiologic features and geographical distribution have been known for several decades. The disease had been found almost only in and around Tokyo areas until the 1970s, but after the 1990s, the disease spread to the rest of Japan. The incidence rate of the disease due to M. kansasii remained at the same level, while non-tuberculous mycobacterioses as a whole are rapidly increasing, especially because of the increase in Mycobacteriu avium complex diseases, and because of the improvement of identification techniques in recent years. This change in the epidemiologic picture of M. kansasii in Japan seems to be influenced by the international trends of this disease. The complicated environmental and other factors related to M. kansasii infection are discussed in this review.
- 1 February 2011
- Vol. 49 (2) , 142-7
[A case of cryptococcal empyema successfully treated by debridement by medical thoracoscopy with local anesthesia].
Cryptococcal empyema is a rare disease which usually occurs in immunocompromised patients. We describe a 57-year-old man with diabetes mellitus with a mass-like shadow in the right middle lung field. Transbronchial lung biopsy of the right lung revealed numerous yeast-like fungi in fibrotic and necrotic lesions. These findings, together with positive serum cryptococcal antigen yielded a diagnosis of pulmonary cryptococcosis secondary to diabetes mellitus. Despite treatment with several anti-fungal drugs, and dyspnea and pleural effusion developed. He was referred to our hospital for further examination and therapy. The presence of positive cryptococcal antigen and numerous yeast-like fungi were confirmed cytologically in the pleural effusion. Therefore, we suspected that pulmonary cryptococcosis had perforated into the thoracic space and empyema had developed. Because antifungal drugs were ineffective, debridement of the fibrinopurulent material by medical thoracoscopy and chest drainage were performed. The clinical symptoms of this patient improved with antifungal treatment for 1 year, and we successfully treated the cryptococcal empyema without recurrence. Debridement by medical thoracoscopy and chest drainage were useful for this case of cryptococcal empyema.
- 1 February 2011
- Vol. 49 (2) , 142-7
[A case of cryptococcal empyema successfully treated by debridement by medical thoracoscopy with local anesthesia].
Cryptococcal empyema is a rare disease which usually occurs in immunocompromised patients. We describe a 57-year-old man with diabetes mellitus with a mass-like shadow in the right middle lung field. Transbronchial lung biopsy of the right lung revealed numerous yeast-like fungi in fibrotic and necrotic lesions. These findings, together with positive serum cryptococcal antigen yielded a diagnosis of pulmonary cryptococcosis secondary to diabetes mellitus. Despite treatment with several anti-fungal drugs, and dyspnea and pleural effusion developed. He was referred to our hospital for further examination and therapy. The presence of positive cryptococcal antigen and numerous yeast-like fungi were confirmed cytologically in the pleural effusion. Therefore, we suspected that pulmonary cryptococcosis had perforated into the thoracic space and empyema had developed. Because antifungal drugs were ineffective, debridement of the fibrinopurulent material by medical thoracoscopy and chest drainage were performed. The clinical symptoms of this patient improved with antifungal treatment for 1 year, and we successfully treated the cryptococcal empyema without recurrence. Debridement by medical thoracoscopy and chest drainage were useful for this case of cryptococcal empyema.
- 1 June 2008
- Vol. 83 (6) , 471-3
[Comparison of BBL Mycoprep and 2%NaOH decontamination procedures for MGIT].
We compared the BBL Mycoprep (Becton Dickinson Japan) and home-made 2%NaOH decontamination procedures by using an equal amount of expectorated sputum in the aerosol-free 30 ml KT centrifuge tube with the rugged inner surface. A total of 113 sputum specimens obtained in NHO Kinki-Chuo Chest Medical Center in November 2004 were subjected to two decontamination methods. All specimens were divided into two equal portions after concentrating the sediments processed by semi-kaline protease (SAP), then decontaminated, and inoculated into MGIT. The tubes were incubated at 37 degrees C and monitored for up to forty-second days. Comparing these decontamination procedures, the time of the recovery of mycobacteria strains in the 2%NaOH (mean 8 days) was significantly faster than in the BBL Mycoprep (mean 11 days). Of these, 19 specimens (16.9%) processed by the BBL Mycoprep were positive for growth of mycobacteria, and similarly 18 specimens (16.0%) processed by the 2%NaOH (p>0.5) were positive. The 19 mycobacteria recovered by the BBL Mycoprep were identified as 14 M. tuberculosis strains and 5 NTM strains. The decontamination rate was 0.9% in 2%NaOH and 6.2% in Mycoprep, however the difference was statistically not significant (p>0.5). We verified that the 2%NaOH was an alternative method suitable for the digestion and decontamination procedure, and 2%NaOH was useful for the isolation and detection of mycobacteria as well.
- 1 June 2008
- Vol. 83 (6) , 471-3
[Comparison of BBL Mycoprep and 2%NaOH decontamination procedures for MGIT].
We compared the BBL Mycoprep (Becton Dickinson Japan) and home-made 2%NaOH decontamination procedures by using an equal amount of expectorated sputum in the aerosol-free 30 ml KT centrifuge tube with the rugged inner surface. A total of 113 sputum specimens obtained in NHO Kinki-Chuo Chest Medical Center in November 2004 were subjected to two decontamination methods. All specimens were divided into two equal portions after concentrating the sediments processed by semi-kaline protease (SAP), then decontaminated, and inoculated into MGIT. The tubes were incubated at 37 degrees C and monitored for up to forty-second days. Comparing these decontamination procedures, the time of the recovery of mycobacteria strains in the 2%NaOH (mean 8 days) was significantly faster than in the BBL Mycoprep (mean 11 days). Of these, 19 specimens (16.9%) processed by the BBL Mycoprep were positive for growth of mycobacteria, and similarly 18 specimens (16.0%) processed by the 2%NaOH (p>0.5) were positive. The 19 mycobacteria recovered by the BBL Mycoprep were identified as 14 M. tuberculosis strains and 5 NTM strains. The decontamination rate was 0.9% in 2%NaOH and 6.2% in Mycoprep, however the difference was statistically not significant (p>0.5). We verified that the 2%NaOH was an alternative method suitable for the digestion and decontamination procedure, and 2%NaOH was useful for the isolation and detection of mycobacteria as well.